NUCB2 and endometrial cancer: Some studies report high expression of NUCB2/nesfatin-1 in type I and type II endometrial cancer tissue [34] while others report an inverse correlation between nesfatin-1 and endometriosis, as serum nesfatin-1 remains low in patients with endometriosis [35].